Short description
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease.
Description
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease. Left undiagnosed, patients remain at risk, incorrect treatment regimes are administered and cost burdens on health systems escalate. With ageing populations and the demand for medical services rising globally, significant delays in reporting can leave patients in critical situations.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Perth, Western Australia, Australia, Oceania
Founded on
January 1, 2019
Exited on
November 26, 2021
Went public on
November 26, 2021
Stock symbol
AYA
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Absolutely Noaccess, Noaccess, Uh Ohhhh, Cannot Access
Sign in for full access
Founders
John Barrington, John Konstantopoulos